News
CEO of Novo Nordisk, maker of Wegovy, is stepping down
Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company’s board of directors, citing “recent market challenges” and a steep decline in the company’s share price.
When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.
Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants ...
One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
Q. I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were ...
Eli Lilly's tirzepatide leads to 50% more weight loss compared to Novo Nordisk's semaglutide in 72-week study.
Novo Nordisk, the company that makes the weight loss drugs Ozempic and Wegovy, is abruptly ousting its chief executive, Lars Fruergaard Jørgensen, over concerns the firm is losing ground in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback